1991
DOI: 10.1016/0002-9378(91)90020-r
|View full text |Cite
|
Sign up to set email alerts
|

Potential role of endothelin-1 in normal and hypertensive pregnancies

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
35
3
3

Year Published

1993
1993
2020
2020

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 84 publications
(44 citation statements)
references
References 25 publications
3
35
3
3
Order By: Relevance
“…One potential pathway by which glucocorticoids may promote vasoconstriction is via the potent vasoconstrictor peptide endothelin-1. Preeclampsia is associated with elevated endothelin-1 in both the maternal (36) and fetal compartments (37) and glucocorticoids have been shown to potentate its vasoconstrictive actions. The female fetus appears to be sensitive to changes in glucocorticoid exposure and therefore may exhibit increased placental vasoconstriction (38) and uteroplacental insufficiency.…”
Section: Resultsmentioning
confidence: 99%
“…One potential pathway by which glucocorticoids may promote vasoconstriction is via the potent vasoconstrictor peptide endothelin-1. Preeclampsia is associated with elevated endothelin-1 in both the maternal (36) and fetal compartments (37) and glucocorticoids have been shown to potentate its vasoconstrictive actions. The female fetus appears to be sensitive to changes in glucocorticoid exposure and therefore may exhibit increased placental vasoconstriction (38) and uteroplacental insufficiency.…”
Section: Resultsmentioning
confidence: 99%
“…Indeed, plasma levels of ET-1 are elevated in preeclampsia as compared with normal pregnancy (Mastrogiannis et al, 1991;Nova et al, 1991;Clark et al, 1992). Furthermore, high levels of ET-1 are closely related with biological markers of renal impairment in preeclampsia (Clark et al, 1992).…”
Section: Resultsmentioning
confidence: 99%
“…The role of ET in pre-eclampsia is unclear, however, as contradictory reports exist concerning circulating ET levels in normotensive patients and those exhibiting this condition. Some reports have shown that prepro-ET-1 gene expression and plasma ET-1 levels are similar in both normal pregnancy and pre-eclampsia (Benigni et al, 1992;Otani et al, 1991), whilst others have reported elevated maternal plasma ET-1 levels in pre-eclampsia implicating ET in the impaired renal function and placental blood flow associated with the disease (Mastrogiannis et al, 1991;Nova et al, 1991;Clark et al, 1992). In the present study, we were unable to detect a difference in either the relative density or proportion of vascular and villous ET receptor imating the equilibrium dissociation constant from saturation data obtained under these conditions was therefore considered inappropriate.…”
Section: Discussionmentioning
confidence: 99%
“…Endothelin (ET) has been shown to be a potent vasoconstrictor of the human isolated foetoplacental cotyledon (Wilkes et al, 1990) and foetoplacental blood vessels (MacLean et al, 1992) and has the potential to influence placental blood flow either directly or in concert with other vasoactive agents including thromboxane A2, prostaglandin F2., prostacyclin, nitric oxide and atrial natriuretic peptide (De Nucci et al, 1988;Hu et al, 1988;Rae et al, 1989;Wilkes et al, 1990;Cameron et al, 1991). Circulating ET levels have been shown to increase during pregnancy and labour (Mastrogiannis et al, 1991); however, conflicting evidence exists concerning the possible role of ET in the pathogenesis of pre-eclampsia. While some reports have indicated a further elevation of plasma ET levels in this condition (Nova et al, 1991;Clark et al, 1992), more recent studies have not found a significant difference in plasma ET levels between pre-eclamptic and normal pregnancies (Benigni et al, 1992) nor any correlation between plasma ET-1 concentration, blood pressure or renal function during toxaemic pregnancy (Otani et al, 1991).…”
Section: Introductionmentioning
confidence: 99%